Use of Gabapentin (Meditan) in Clinical Practice of Neurologist from the Standpoint of Evidence-Based Medicine

R.V. Svistilnik

Abstract


This review article summarizes the possible use of anticonvulsant agent gabapentin (Meditan) in clinical practice for a variety of diseases of both central and peripheral nervous system from the standpoint of evidence-based medicine and the recent guidelines of European Federation of Neurological Societies (EFNS), British National Institute for Health and Care Excellence (NICE), American Academy of Neurology (AAN) and some leading associations and societies.


Keywords


gabapentin; Meditan®; pain; pharmacotherapy

References


Маликова Л.А. Влияние леветирацетама на содержание медиаторных аминокислот в структурах мозга крыс при аудиогенном эпилептиформном припадке / Л.А. Маликова,

И.Б. Федотова, П.М. Клодт // Психофармакол. и биол. наркол. — 2008. — Т. 8, № 3–4. — С. 2448-2452.

Кукушкин М.Л. Неврогенная (невропатическая) боль / М.Л. Кукушкин // Лекарственный вестник. — 2006. — № 6. — C. 61-64.

American Epilepsy Society Subcommittee of the American Academy of Neurology and the Technology Assessment Subcommittee and Quality Standards Treatment of new onset epilepsy: Report of the Therapeutics and Efficacy and tolerability of the new antiepileptic drugs I / J.A. French, A.M. Kanner, J. Bautista [et al.] // Neuro-logy. — 2004. — Vol. 62. — P. 1252-1260.

American Epilepsy Society Subcommittee of the American Academy of Neurology and the Technology Assessment Subcommittee and Quality Standards Treatment of new onset epilepsy: Report of the Therapeutics and Efficacy and tolerability of the new antiepileptic drugs II / J.A. French, A.M. Kanner, J. Bautista [et al.] // Neuro-logy. — 2004. — Vol. 62. — P. 1261-1273.

A Randomized Study of the Effects of Single-dose Gabapentin versus Placebo on Postoperative Pain and Morphine Consumption after Mastectomy / J. Dirks, B.B. Fredensborg, D. Christensen

[et al.] // Anesthesiology. — 2002. — Vol. 97. — P. 560-564.

Coetzer R. Postherpetic neuralgia / R. Coetzer // S. Afr. Pharm. J. — 2011. — V. 78. — P. 36-39.

Complex Regional Pain Syndrome: Practical Diagnostic and Treatment Guidelines, 4th Edition / R.N. Harden, A.L. Oaklander, A.W. Burton [et al.] // Pain Medicine. — 2013. — P. 50.

Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society / R. Chou, A. Qaseem, V. Snow [et al.] // Ann. Intern. Med. — 2007. — Vol. 147. — P. 478-491.

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision / N. Attal, G. Cruccu, R. Baron [et al.] // European Journal of Neurology. — 2010. — Vol. 17. —

P. 1113-1123.

EFNS guideline on the drug treatment of migraine — revised report of an EFNS task force / S. Evers, J. Afra, A. Frese [et al.] // European Journal of Neurology. — 2009. — Vol. 16. —

P. 968-981.

Evidence-based guideline update: Treatment of essential tremor: Report of the Quality Standards Subcommittee of the American Academy of Neurology / T.A. Zesiewicz, R.J. Elble, E.D. Louis [et al.] // Neurology. — 2011. — Vol. 77. — P. 1752-1755.

Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology / D.S. Baldwin, I.M. Anderson, D.J. Nutt [et al.] // Psychopharm. Journal of Psychopharmacology. — 2005. — Vol. 19. — P. 567-596.

Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation / V. Bril, J. England, G.M. Franklin [et al.] // Neurology. — 2011. — Vol. 76. — P. 1758-1765.

FDA approves Horizant to treat restless legs syndrome / FDA NEWS, 07.04.2011 // http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ ucm250188.htm.

Gabapentin premedication: assessment of preoperative anxiolysis and postoperative patient satisfaction / M. Tirault, L. Foucan, B. Debaene [et al.] // Acta Anaesth. Belg. — 2010. — Vol. 61. — P. 203-209.

Gabapentin Does Not Reduce Preoperative Anxiety When Given Prior to Total Hip Arthroplasty / H. Clarke, J. Kay, B.A. Or-ser [et al.] // Pain Medicine. — 2010. — Vol. 11. — P. 966-971.

Gabapentin monotherapy in patients with chronic radiculopathy: the efficacy and impact on life quality / K. Yildirim, O. Deniz, G. Gureser [et al.] // J. Back Musculoskelet Rehabil. — 2009. — Vol. 22. — P. 17-20.

Gharibo C. Neuropathic pain of postherpetic neuralgia / C. Gharibo, C. Kim // Pain medicine news. — 2011. — №. 12. — P. 84-92.

Gamma-Aminobutyric Acid (GABA) // Alternative Medicine Review. — 2007. — Vol. 12. — P. 274-279.

Honarmand A. Gabapentin: An update of its pharmacological properties and therapeutic use in epilepsy / A. Honarmand, M. Safavi, M. Zare // J. Res. Med. Sci. — 2011. — Vol. 16. — P. 1062-1069.

Implications and mechanism of action of gabapentin in neuropathic pain / A. Kukkar, A. Bali, N. Singh, A.S. Jaggi // Arch. Pharm. Res. — 2013. — Vol. 36. — P. 237-251.

Koch K. Postherpetic neuralgia in everyday practice / K. Koch // S. Afr. Fam. Pract. — 2012. — Vol. 54. — P. 487-490.

McCleane G. Does gabapentin have an analgesic effect on background, movement and referred pain? A randomised, double-blind, placebo controlled study / G. McCleane // The Pain Clinic. — 2001. — Vol. 13. — P. 103-107.

Mackey S. Pharmacologic Therapies for Complex Regional Pain Syndrome / S. Mackey, S. Feinberg // Curr. Pain Headache Rep. — 2007. — Vol. 11. — P. 38-43.

MacEwan A. Gabapentin / A. MacEwan, G. McKay, M. Fisher // Pract. Diab. Int. — 2009. — Vol. 26. — P. 206-207.

McLean M.J. Gabapentin dosing in the treatment of epilepsy / M.J. McLean, B.E. Gidal // Clin. Ther. — 2003. — Vol. 25. — P. 1382-406.

Melvin G. Drug therapy for trigeminal neuralgia / G. Melvin, S. Sandhiya, C. Indumathi // Journal of Dentistry. — 2001. — Vol. 1, Issue 2. — P. 28-31.

National Institute for Health and Care Excellence (NICE) Neuropathic pain — pharmacological management: the pharmacological management of neuropathic pain in adults in non-specialist settings. Qinical guideline 173. — London, UK: NICE, 2013. — Р. 41.

Pathak L. Effect of gabapentin premedication on preoperative anxiety and postoperative pain / L. Pathak, A. Chaturvedi // Health Renaissance. — 2013. — Vol. 11. — P. 254-259.

Practice Guidelines for Chronic Pain Management. An Updated Report by the American Society of Anesthesiologists Task Force on Chronic Pain Management and the American Society of Regional Anesthesia and Pain Medicine // Anesthesiology. — 2010. — Vol. 112. — P. 1-24.

Protective effect of gabapentin on N-methyl-D-aspartate-induced excitotoxicity in rat hippocampal CA1 neurons / Y.S. Kim, H.K. Chang, J.W. Lee [et al.] // J. Pharmacol. Sci. — 2009. — Vol. 109. — P. 144-147.

Qazi J.A. Gabapentin for the treatment of trigeminal neura-lgia / J.A. Qazi, W.-U.-R. Qureshi, A.H. Qaz // Pakistan Oral & Dental Journal. — 2012. — Vol. 32, № 2. — Р. 218-221.

Recommendations for the Management of Idiopathic Trigeminal Neuralgia / C.P. Ping, J.W.Y. Ip, J.M.K. Lam [et al.] // Medical Progress. — 2003. — Vol. 30. — P. 13-20.

Rose M.A. Gabapentin: pharmacology end its use in pain management / M.A. Rose, C.A. Kam // Anaesthesia. — 2002. — Vol. 57. — P. 451-462.

Straube A. Nystagmus and oscillopsia / A. Straube, A. Bronstein, D. Straumann // European Handbook of Neurological Management / Edited by N.E. Gilhus, M.P. Barnes and M. Brainin. — Blackwell Publishing Ltd. — 2011. — Vol. 1, 2nd Edition. — P. 459-468.

Tampi R.R. Gabapentin for the treatment of behavioral and psychological symptoms of dementia / R.R. Tampi, B. Ozkan,

D. Williamson // Advances in Alzheimer’s Disease. — 2012. — Vol. 1. — P. 13-16.

The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders /

A. Schaffer, D. McIntosh, B.I. Goldstein [et al.] // Annals of Clinical Psychiatry. — 2012. — Vol. 24. — P. 6-22.

The effectiveness of gabapentin in patients with chronic radiculopathy / K. Yildirim, M. Sisecioglu, S. Karatay [et al.] // The Pain Clinic. — 2003. — Vol. 15. — P. 213-218.

Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes / T. Glauser, E. Ben-Menachem, B. Bourgeois [et al.] // Epilepsia. — 2013. — Vol. 54. — P. 551-563.

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders — first revision / B. Bandelow, J. Zohar, E. Hollander, S. Kasper, H.J. Moller, WFSBP Task Force on Treatment Guidelines for Anxiety O-CaP-TSD // World J. Biol. Psychiatry. — 2008. — Vol. 9. —

P. 248-312.




DOI: https://doi.org/10.22141/2224-0713.5.67.2014.80707

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 INTERNATIONAL NEUROLOGICAL JOURNAL

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru